Connection
Jay Portnoy to Albuterol
This is a "connection" page, showing publications Jay Portnoy has written about Albuterol.
|
|
Connection Strength |
|
 |
|
 |
|
0.078 |
|
|
|
-
Shaker MS, Oppenheimer J, Grayson M, Stukus D, Hartog N, Hsieh EWY, Rider N, Dutmer CM, Vander Leek TK, Kim H, Chan ES, Mack D, Ellis AK, Lang D, Lieberman J, Fleischer D, Golden DBK, Wallace D, Portnoy J, Mosnaim G, Greenhawt M. Reply to "Subcutaneous terbutaline as an alternative to aerosolized albuterol". J Allergy Clin Immunol Pract. 2020 Jul - Aug; 8(7):2450-2452.
Score: 0.045
-
Guss S, Portnoy J. Methotrexate treatment of severe asthma in children. Pediatrics. 1992 Apr; 89(4 Pt 1):635-9.
Score: 0.026
-
Wiens L, Sabath R, Ewing L, Gowdamarajan R, Portnoy J, Scagliotti D. Chest pain in otherwise healthy children and adolescents is frequently caused by exercise-induced asthma. Pediatrics. 1992 Sep; 90(3):350-3.
Score: 0.007
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|